The Locus Coeruleus-Norepinephrine Network Optimizes Coupling of Cerebral Blood Volume with Oxygen Demand

Given the brain's uniquely high cell density and tissue oxygen levels bordering on hypoxia, the ability to rapidly and precisely match blood flow to constantly changing patterns in neural activity is an essential feature of cerebrovascular regulation. Locus coeruleus-norepinephrine (LC-NE) projections innervate the cerebral vasculature and can mediate vasoconstriction. However, function of the LC-mediated constriction in blood-flow regulation has never been addressed. Here, using intrinsic optical imaging coupled with an anesthesia regimen that only minimally interferes with LC activity, we show that NE enhances spatial and temporal aspects of functional hyperemia in the mouse somatosensory cortex. Increasing NE levels in the cortex using an α2-adrenergic receptor antagonist paradoxically reduces the extent of functional hyperemia while enhancing the surround blood-flow reduction. However, the NE-mediated vasoconstriction optimizes spatial and temporal focusing of the hyperemic response resulting in a sixfold decrease in the disparity between blood volume and oxygen demand. In addition, NE-mediated vasoconstriction accelerated redistribution to subsequently active regions, enhancing temporal synchronization of blood delivery. These observations show an important role for NE in optimizing neurovascular coupling. As LC neuron loss is prominent in Alzheimer and Parkinson diseases, the diminished ability to couple blood volume to oxygen demand may contribute to their pathogenesis.

[1]  R. Buxton Neuroenergetics Review Article , 2022 .

[2]  B. K. Hartman,et al.  Central noradrenergic regulation of cerebral blood flow and vascular permeability. , 1975, Proceedings of the National Academy of Sciences of the United States of America.

[3]  C. Iadecola Neurovascular regulation in the normal brain and in Alzheimer's disease , 2004, Nature Reviews Neuroscience.

[4]  M. Raichle,et al.  Focal physiological uncoupling of cerebral blood flow and oxidative metabolism during somatosensory stimulation in human subjects. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[5]  M. Nelson,et al.  Potassium channels and neurovascular coupling. , 2010, Circulation journal : official journal of the Japanese Circulation Society.

[6]  Anlong Li,et al.  Downloaded from http://circres.ahajournals.org / by guest on February 23, 2013Astrocyte-Derived CO Is a Diffusible Messenger That Mediates Glutamate-Induced Cerebral Arteriolar Dilation by Activating Smooth Muscle Cell K Ca Channels , 2008 .

[7]  B. MacVicar,et al.  Calcium transients in astrocyte endfeet cause cerebrovascular constrictions , 2004, Nature.

[8]  J. Rossier,et al.  Cortical GABA Interneurons in Neurovascular Coupling: Relays for Subcortical Vasoactive Pathways , 2004, The Journal of Neuroscience.

[9]  P. Yates,et al.  The topography of cell loss from locus caeruleus in Alzheimer's disease , 1986, Journal of the Neurological Sciences.

[10]  K. Ohta,et al.  Locus coeruleus stimulation exerts different influences on the dynamic changes of cerebral pial and intraparenchymal vessels. , 1991, Neurological research.

[11]  Hee-Sup Shin,et al.  Adrenergic facilitation of GABAergic transmission in rat entorhinal cortex. , 2007, Journal of neurophysiology.

[12]  N. Logothetis,et al.  Negative functional MRI response correlates with decreases in neuronal activity in monkey visual area V1 , 2006, Nature Neuroscience.

[13]  M. Mintun,et al.  Brain work and brain imaging. , 2006, Annual review of neuroscience.

[14]  L. Hertz,et al.  Astrocytic adrenoceptors: a major drug target in neurological and psychiatric disorders? , 2004, Current drug targets. CNS and neurological disorders.

[15]  T. Klockgether,et al.  Noradrenergic Depletion Potentiates β-Amyloid-Induced Cortical Inflammation: Implications for Alzheimer's Disease , 2002, The Journal of Neuroscience.

[16]  T. Murphy,et al.  Rapid Astrocyte Calcium Signals Correlate with Neuronal Activity and Onset of the Hemodynamic Response In Vivo , 2007, The Journal of Neuroscience.

[17]  Grant R. Gordon,et al.  Brain metabolism dictates the polarity of astrocyte control over arterioles , 2008, Nature.

[18]  D. Attwell,et al.  Bidirectional control of CNS capillary diameter by pericytes , 2006, Nature.

[19]  C. Carter,et al.  Presynaptic alpha-2 adrenoceptors play a major role in the effects of idazoxan on cortical noradrenaline release (as measured by in vivo dialysis) in the rat. , 1987, The Journal of pharmacology and experimental therapeutics.

[20]  Kortaro Tanaka,et al.  Comparison between Pial and Intraparenchymal Vascular Responses to Cervical Sympathetic Stimulation in Cats. Part 1. Under Normal Resting Conditions , 1986, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[21]  M. Raskind,et al.  A comprehensive analysis of the effect of DSP4 on the locus coeruleus noradrenergic system in the rat , 2010, Neuroscience.

[22]  F. Colpaert,et al.  In vivo upregulation of endogenous NGF in the rat brain by the alpha 2-adrenoreceptor antagonist dexefaroxan: potential role in the protection of the basalocortical cholinergic system during neurodegeneration , 2004, Experimental Neurology.

[23]  X. Tong,et al.  GABA neurons provide a rich input to microvessels but not nitric oxide neurons in the rat cerebral cortex: A means for direct regulation of local cerebral blood flow , 2000, The Journal of comparative neurology.

[24]  E. Hamel,et al.  Journal of Cerebral Blood Flow and Metabolism Astroglial and Vascular Interactions of Noradrenaline Terminals in the Rat Cerebral Cortex , 2022 .

[25]  F. Jaw,et al.  A New Scenario for Negative Functional Magnetic Resonance Imaging Signals: Endogenous Neurotransmission , 2009, The Journal of Neuroscience.

[26]  D. Ts'o,et al.  Cortical functional architecture and local coupling between neuronal activity and the microcirculation revealed by in vivo high-resolution optical imaging of intrinsic signals. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[27]  A. Rosenquist,et al.  Noradrenergic mechanisms in neurodegenerative diseases: a theory , 2004, Brain Research Reviews.

[28]  B. Zlokovic Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders , 2011, Nature Reviews Neuroscience.

[29]  Andrei G. Vlassenko,et al.  Increased lactate/pyruvate ratio augments blood flow in physiologically activated human brain. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[30]  J. Fritschy,et al.  Immunohistochemical analysis of the neurotoxic effects of DSP-4 identifies two populations of noradrenergic axon terminals , 1989, Neuroscience.

[31]  D. Kleinfeld,et al.  Stimulus-Induced Changes in Blood Flow and 2-Deoxyglucose Uptake Dissociate in Ipsilateral Somatosensory Cortex , 2008, The Journal of Neuroscience.

[32]  Jonathan D. Cohen,et al.  Decision making, the P3, and the locus coeruleus-norepinephrine system. , 2005, Psychological bulletin.

[33]  A. Pertovaara,et al.  Pharmacological properties, central nervous system effects, and potential therapeutic applications of atipamezole, a selective alpha2-adrenoceptor antagonist. , 2006, CNS drug reviews.

[34]  Wei He,et al.  Locus coeruleus alpha-adrenergic-mediated activation of cortical astrocytes in vivo. , 2008, Cerebral cortex.

[35]  D. Mann,et al.  The topography of nerve cell loss from the locus caeruleus in elderly persons , 1989, Neurobiology of Aging.

[36]  R. Koehler,et al.  Interaction of nitric oxide, 20-HETE, and EETs during functional hyperemia in whisker barrel cortex. , 2008, American journal of physiology. Heart and circulatory physiology.

[37]  Chris Zarow,et al.  Neuronal loss is greater in the locus coeruleus than nucleus basalis and substantia nigra in Alzheimer and Parkinson diseases. , 2003, Archives of neurology.

[38]  J. Sirviö,et al.  The effects of a specific alpha(2)-adrenoceptor antagonist, atipamezole, on cognitive performance and brain neurochemistry in aged Fisher 344 rats. , 2000, European journal of pharmacology.

[39]  D. Johnston,et al.  Negative Blood Oxygen Level Dependence in the Rat:A Model for Investigating the Role of Suppression in Neurovascular Coupling , 2010, The Journal of Neuroscience.

[40]  Mathias Hoehn,et al.  Locus Ceruleus Degeneration Promotes Alzheimer Pathogenesis in Amyloid Precursor Protein 23 Transgenic Mice , 2006, The Journal of Neuroscience.

[41]  Andrei G. Vlassenko,et al.  Regulation of blood flow in activated human brain by cytosolic NADH/NAD+ ratio. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[42]  C. Berridge,et al.  The locus coeruleus–noradrenergic system: modulation of behavioral state and state-dependent cognitive processes , 2003, Brain Research Reviews.

[43]  B. Duling,et al.  Effect of norepinephrine on penetrating arterioles of rat cerebral cortex. , 1984, The American journal of physiology.

[44]  K. Uğurbil,et al.  Effect of Basal Conditions on the Magnitude and Dynamics of the Blood Oxygenation Level-Dependent fMRI Response , 2002, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[45]  Nikos K Logothetis,et al.  The ins and outs of fMRI signals , 2007, Nature Neuroscience.

[46]  D. Kleinfeld,et al.  Suppressed Neuronal Activity and Concurrent Arteriolar Vasoconstriction May Explain Negative Blood Oxygenation Level-Dependent Signal , 2007, The Journal of Neuroscience.

[47]  G. Aston-Jones,et al.  A novel long-latency response of locus coeruleus neurons to noxious stimuli: mediation by peripheral C-fibers. , 1994, Journal of neurophysiology.

[48]  Dae-Shik Kim,et al.  Origin of Negative Blood Oxygenation Level—Dependent fMRI Signals , 2002, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[49]  J. Fritschy,et al.  Selective effects of DSP-4 on locus coeruleus axons: are there pharmacologically different types of noradrenergic axons in the central nervous system? , 1991, Progress in brain research.